Interleukin-2 messenger RNA (IL2 mRNA) (IL2 mRNA)

Interleukin-2 (IL-2) messenger RNA (mRNA) is the primary transcript of the IL2 gene, serving as the essential template for the synthesis of the IL-2 cytokine, which orchestrates the activation, proliferation, and survival of T-lymphocytes (NCBI Gene ID: 3558). The production of endogenous IL-2 mRNA is a tightly controlled process initiated upon T-cell receptor (TCR) stimulation, primarily involving the activation of the calcineurin-NFAT signaling pathway which triggers transcription (StatPearls, NBK482450). Post-transcriptional regulation also plays a vital role, where the stability and half-life of the mRNA are modulated by RNA-binding proteins interacting with AU-rich elements in its 3' untranslated region (PubMed, 11017147). Because IL-2 is a central driver of immune activity, its mRNA is a critical focal point for therapeutic intervention in conditions characterized by immune overactivity, such as organ transplant rejection and autoimmune diseases. Historically, immunosuppressants like cyclosporine and tacrolimus have targeted the signaling pathways required for IL-2 mRNA transcription to achieve therapeutic effects (StatPearls, NBK482450). More recently, the mRNA itself has emerged as a potential direct target for antisense oligonucleotides (ASOs) and RNA interference (siRNA) technologies aimed at modulating the immune response with high specificity (PubMed, 10611318).

Other names

IL-2 mRNAT-cell growth factor mRNATCGF mRNAInterleukin 2 mRNA

Inhibition of transcription via calcineurin-NFAT pathway blockade; experimental degradation via antisense oligonucleotides (ASOs) or small interfering RNA (siRNA).